Status:

COMPLETED

Additional Low Voltage Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation

Lead Sponsor:

The First Affiliated Hospital with Nanjing Medical University

Collaborating Sponsors:

The Affiliated Hospital of Xuzhou Medical University

First Affiliated Hospital of Wannan Medical College

Conditions:

Paroxysmal Atrial Fibrillation

Eligibility:

All Genders

65-80 years

Phase:

NA

Brief Summary

The primary objective of this investigation is to compare the efficacy of two different AF ablation strategies in older patients with paroxysmal AF: Pulmonary vein isolation alone versus additional lo...

Detailed Description

BACKGROUND: Atrial fibrillation (AF) is the most common cardiac rhythm disorder. Catheter ablation to the pulmonary veins isolation (PVI) electrically from the left atrium (LA) has been shown to be an...

Eligibility Criteria

Inclusion

  • Patients age is 65-80 years;
  • Patients with paroxysmal AF;
  • Patients can sign the written informed consent for the study;
  • Patients can endure the required follow-up.

Exclusion

  • Patients with previous radiofrequency ablation;
  • Patients with PLT count less than 80×109/L, or with contraindications to systemic anticoagulation with heparin or Coumadin or a direct thrombin inhibitor;
  • Patients with left atrial size ≥ 55 mm (2D echocardiography, parasternal long-axis view);
  • Patients with thromboemboli in LA (TEE or MSCT);
  • Patients with severe structural cardiac disease (medium or severe mitral regurgitation, DCM, HCM, or other severe valvular heart diseases);
  • Patients with abnormal thyroid function;
  • Patients with severe liver or renal dysfunction (AST or ALT \> 3-fold of upper limit value; the SCr \> 3.5 mg/dl or Ccr \< 30 ml/min);
  • Previous surgery history in last 3 months;
  • Patients with life expectancy \< 12 months

Key Trial Info

Start Date :

April 24 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 17 2021

Estimated Enrollment :

438 Patients enrolled

Trial Details

Trial ID

NCT03462628

Start Date

April 24 2018

End Date

August 17 2021

Last Update

May 4 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

the First Affiliated Hospital of Nanjing Medical University

Nanjing, China